See also this year's filing and all EDGAR filings for this company.
PDF Report 0001260990_2019_Oncternal_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001260990, Oncternal Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 31,208,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 94,000 |
| 2 | PropertyPlantAndEquipmentNet | 19,000 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 5,210,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 9,346,899 |
| 9 | ResearchAndDevelopmentExpense | 32,702,220 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 514,892 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 31,321,000 |
| 1 | Liabilities | 5,210,000 |
| 2 | Expenses | 42,049,119 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 26,111,000 |
| 5 | NetIncome | -41,534,227 |
| 6 | ComprehensiveNetIncome | -41,534,227 |
| 7 | BaseVar | 39,547,506 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.842 |
| 9 | EconomicCapitalRatio | 2.18 |